CY1121253T1 - Μεθοδος παραγωγης μεγαλης κλιμακας του διυδροχλωρικου ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου - Google Patents

Μεθοδος παραγωγης μεγαλης κλιμακας του διυδροχλωρικου ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου

Info

Publication number
CY1121253T1
CY1121253T1 CY20181101122T CY181101122T CY1121253T1 CY 1121253 T1 CY1121253 T1 CY 1121253T1 CY 20181101122 T CY20181101122 T CY 20181101122T CY 181101122 T CY181101122 T CY 181101122T CY 1121253 T1 CY1121253 T1 CY 1121253T1
Authority
CY
Cyprus
Prior art keywords
yloxy
phenyl
cyclovutylopiperidin
dihydrochlorate
morfolin
Prior art date
Application number
CY20181101122T
Other languages
English (en)
Inventor
Ramakrishna Nirogi
Anil Karbhari Shinde
Ramasastri Kambhampati
Venkateswarlu Jasti
Original Assignee
Suven Life Sciences Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suven Life Sciences Limited filed Critical Suven Life Sciences Limited
Publication of CY1121253T1 publication Critical patent/CY1121253T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Η παρούσα εφεύρεση αναφέρεται σε μια διαδικασία παραγωγής μεγάλης κλίμακας του διυδροχλωρικού Ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου του Χημικού Τύπου (I).
CY20181101122T 2014-08-16 2018-10-30 Μεθοδος παραγωγης μεγαλης κλιμακας του διυδροχλωρικου ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου CY1121253T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4010CH2014 2014-08-16
PCT/IN2014/000666 WO2016027275A1 (en) 2014-08-16 2014-10-20 Process for large scale production of n-[4-(1- cyclobutyl piperidin-4-yloxy) phenyl]-2-(morpholin-4-yl) acet amide dihydrochloride

Publications (1)

Publication Number Publication Date
CY1121253T1 true CY1121253T1 (el) 2020-05-29

Family

ID=52339255

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181101122T CY1121253T1 (el) 2014-08-16 2018-10-30 Μεθοδος παραγωγης μεγαλης κλιμακας του διυδροχλωρικου ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου

Country Status (28)

Country Link
US (1) US9802896B2 (el)
EP (1) EP3180334B1 (el)
JP (1) JP6385580B2 (el)
KR (1) KR101860487B1 (el)
CN (1) CN106573925B (el)
AP (1) AP2017009753A0 (el)
AU (1) AU2014403999B2 (el)
BR (1) BR112017002922B1 (el)
CA (1) CA2957494C (el)
CY (1) CY1121253T1 (el)
DK (1) DK3180334T3 (el)
EA (1) EA032823B1 (el)
ES (1) ES2693378T3 (el)
HK (1) HK1231472A1 (el)
HR (1) HRP20181801T1 (el)
HU (1) HUE041465T2 (el)
IL (1) IL250412B (el)
LT (1) LT3180334T (el)
MX (1) MX364931B (el)
NZ (1) NZ728915A (el)
PL (1) PL3180334T3 (el)
PT (1) PT3180334T (el)
RS (1) RS57927B1 (el)
SG (1) SG11201701104SA (el)
SI (1) SI3180334T1 (el)
TR (1) TR201816175T4 (el)
WO (1) WO2016027275A1 (el)
ZA (1) ZA201700936B (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019229509A1 (en) * 2018-05-31 2019-12-05 Suven Life Sciences Limited Method of treatment with histamine-3 receptor inverse agonist

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904738D0 (sv) * 1999-12-22 1999-12-22 Astra Pharma Prod Novel compounds
CN103415510B (zh) * 2011-02-04 2016-01-13 庵原化学工业株式会社 氨苯基嘧啶基醇衍生物的制备方法及其合成中间体
BR112013021496B1 (pt) * 2011-02-23 2021-10-13 Suven Life Sciences Limited Composto, composição farmacêutica, uso da composição farmacêutica, processo para a preparação de um composto e uso do composto

Also Published As

Publication number Publication date
IL250412A0 (en) 2017-03-30
JP6385580B2 (ja) 2018-09-05
ES2693378T3 (es) 2018-12-11
WO2016027275A1 (en) 2016-02-25
CA2957494A1 (en) 2016-02-25
MX364931B (es) 2019-05-14
US20170260135A1 (en) 2017-09-14
EP3180334A1 (en) 2017-06-21
LT3180334T (lt) 2018-11-12
EA201790388A1 (ru) 2017-06-30
HRP20181801T1 (hr) 2018-12-28
PT3180334T (pt) 2018-11-16
JP2017525761A (ja) 2017-09-07
BR112017002922B1 (pt) 2023-01-03
BR112017002922A2 (pt) 2017-12-05
CN106573925B (zh) 2020-04-10
ZA201700936B (en) 2019-07-31
MX2017002043A (es) 2017-05-04
DK3180334T3 (en) 2018-11-26
HUE041465T2 (hu) 2019-05-28
SI3180334T1 (sl) 2019-01-31
RS57927B1 (sr) 2019-01-31
HK1231472A1 (zh) 2017-12-22
AU2014403999A1 (en) 2017-02-23
KR101860487B1 (ko) 2018-05-23
AU2014403999B2 (en) 2017-12-14
IL250412B (en) 2019-11-28
PL3180334T3 (pl) 2019-03-29
AP2017009753A0 (en) 2017-02-28
KR20170036044A (ko) 2017-03-31
EP3180334B1 (en) 2018-09-26
SG11201701104SA (en) 2017-03-30
TR201816175T4 (tr) 2018-11-21
US9802896B2 (en) 2017-10-31
CN106573925A (zh) 2017-04-19
NZ728915A (en) 2018-01-26
CA2957494C (en) 2018-08-28
EA032823B1 (ru) 2019-07-31

Similar Documents

Publication Publication Date Title
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
CY1121602T1 (el) Συνθεση της κοπανλισιμπης και του διυδροχλωρικου αλατος της
CL2015002309A1 (es) Proceso de fabricacion de vortioxetina.
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
IT201600105178A1 (it) Procedimento per la produzione di dieni
CY1121253T1 (el) Μεθοδος παραγωγης μεγαλης κλιμακας του διυδροχλωρικου ν-[4-(1-κυκλοβουτυλοπιπεριδιν-4-υλοξυ)φαινυλ]-2-(μορφολιν-4-υλ)ακεταμιδιου
MA50917A (fr) Nouvelles formes cristallines du sel monosodique du foramsulfuron
DK3749668T3 (da) Kontinuerlig fremgangsmåde til fremstilling af trazodonbase
MX2017007670A (es) Metodo de manufactura de proteina.
CY1124594T1 (el) Καινοφανης πολυμορφικη μορφη της υδροχλωρικης ν-[2-(6-φθορο-lη-ινδολ-3-υλ)αιθυλ]-3-(2,2,3,3-τετραφθοροπροποξυ)βενζυλαμινης για την αγωγη της αλτσχαϊμεp
EA201491913A1 (ru) Синтез калебина-а и его биологически активных аналогов
DK3247699T3 (da) Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
BR112017007905A2 (pt) processo de incrustação reduzida para a produção de metil metacrilato
EA201790238A1 (ru) Кристаллические ингибиторы bace
BR112016028700A2 (pt) processo para preparação de 3,5-bis(haloalquil)pirazoles via acilação de cetiminas
CY1121313T1 (el) Φαρμακευτικη διεργασια και ενδιαμεσα
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
TH1701000768A (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
TH169412B (th) กระบวนการสำหรับการผลิตขนาดใหญ่ของ n-[4-(1-ไซโคลบิวทิลพิเพอริดิน-4- อิลอกซี)เฟนิล]-2-(มอร์โฟลิน-4-อิล)อะซีตาไมด์ไดไฮโดรคลอไรด์
CY1122343T1 (el) Μεθοδοι για την κατασκευη παραγωγων ινδαζολιου
BR112018012696A2 (pt) processo aperfeiçoado para fabricação de crotonilaminopiridinas
EA201892405A1 (ru) Синтез индазолов
MX2016010549A (es) Indol- y bencimidazolcarboxamidas como insecticidas y acaricidas.
CY1116366T1 (el) Νεα μεθοδος για τη συνθεση αγομελατινης